The neurochemistry of phenylketonuria

European Journal of Pediatrics, Supplement

Volumn 159, Issue 2, 2000, Pages

  Surtees, R ^a   Blau, N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Central nervous system; Demyelination; Hyperphenylalaninaemia; Neurotransmitters; Phenylalanine hydroxylase deficiency

Indexed keywords

METHIONINE; NEUROTRANSMITTER; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TYROSINE;

AMINO ACID BLOOD LEVEL; CONFERENCE PAPER; DEMYELINATION; HUMAN; HYPERPHENYLALANINEMIA; NEUROCHEMISTRY; NEUROTRANSMISSION; PATHOGENESIS; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0033827010     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014370     Document Type: Conference Paper

References (41)

1. Lowering brain phenylalanine levels by giving other large neutral amino acids. A new experimental therapeutic approach to phenylketonuria
2. Concentrations of phenylalanine and tyrosine in plasma and brain of rats treated with phenylalanine loads
3. The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids
4. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia
5. Effect of excess phenylalanine and of other amino acids on brain development in the infant rat
6. Magnetic resonance imaging of the brain in phenylketonuria
7. Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change
8. Pathogenesis of phenylketonuria: Inhibition of DOPA and catecholamine synthesis in patients with phenylketonuria
9. Evidence for the importance of dopamine for prefrontal cortex functions early in life
10. An animal model of early-treated PKU
11. Evidence for central nervous system glial cell plasticity in phenylketonuria
12. Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity
13. Myelin turnover at later stages of brain development in experimental hyperphenylalaninaemia
14. On the mechanism of permanent brain dysfunction in hyperphenylalaninemia
15. The control of 5-hydroxytryptamine and dopamine synthesis in the brain: A theoretical approach
16. Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse
17. Brain development in experimental hyperphenylalaninaemia: Myelination
18. Brain development in experimental hyperphenylalaninaemia: Disturbed proliferation and reduced cell numbers in the cerebellum
19. The effects of hyperphenylalaninaemia on the concentrations of aminoacyl-transfer ribonucleic acid in vivo. A mechanism for the inhibition of neural protein synthesis by phenylalanine
20. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria
21. Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan
22. Dopamine precursors and brain function in phenylalanine hydroxylase deficiency
23. Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine
24. Regional distribution of the phenylalanine-sensitive ATP-sulphurylase in brain
25. Properties of the 3'-phosphoadenosine-5'-phosphosulfate (PAPS) synthesizing systems of brain and liver
26. Spasticity and white matter abnormalities in adult phenylketonuria
27. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain
28. The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain
29. Purification and cloning of the GTP cyclohydrolase I feedback regulatory protein, GFRP
30. In-vivo NMR spectroscopy in patients with phenylketonuria: Changes of cerebral phenylalanine levels under dietary treatment
31. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo
32. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy
33. 75Se in phenylketonuria
34. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids
35. Hyperphenylalaninemia and pterin metabolism in serum and erythrocytes
36. Inhibition of cerebral protein kinase activity and cyclic AMP-dependent ribosomal-protein phosphorylation in experimental hyperphenylalaninaemia
37. 14C-labelled glucose into total lipids
38. Intelligence and quality of dietary treatment in phenylketonuria
39. Neurological deterioration in young adults with phenylketonuria
40. Brain MRI changes in phenylketonuria. Associations with dietary status
41. Neurological findings in early treated phenylketonuria